Skip to main content

2022 Midyear Clinical Meeting & Exhibition Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

149 Views

Federal Forum

(1-285) Evaluation of Prescribing Trends for Newly Approved Naloxone HCl Nasal Spray 8mg (Kloxxado™) to Naloxone HCl Nasal Spray 4mg (Narcan®) to Prevent Opioid Overdose

Sunday, December 4, 2022

3:30 PM – 5:00 PM

Location: Bayside A, Level 1

Category: Research-in-Progress
Topic: Psychiatry/Neurology

Co-Author(s): Madeline Salsman, Monica Barrett, Olivia Howard

Primary Author(s)

Sean Blaeser, PharmD
PGY1 Pharmacy Resident
VA TVHS, Tennessee